interleukin-1-beta
information and resources from the National Cancer Institute
NCI Thesaurus | interleukin-1-beta
A recombinant therapeutic agent which is chemically identical to or similar to the endogenous protein cytokine interleukin 1 (IL-1)-beta. Produced by monocytes and activated macrophages, endogenous mature IL-1 is generated through proteolytic cleavage by proteases such as IL-1-beta converting enzyme (ICE). This agent promotes angiogenesis, fibroblast proliferation, and neutrophil chemotaxis; it also regulates the functions of lymphocytes and epithelial cells and is involved in the 'acute phase response' to infection. NCI Thesaurus | interleukin-1-beta
A recombinant therapeutic agent which is chemically identical to or similar to the endogenous protein cytokine interleukin 1 (IL-1)-beta. Produced by monocytes and activated macrophages, endogenous mature IL-1 is generated through proteolytic cleavage by proteases such as IL-1-beta converting enzyme (ICE). This agent promotes angiogenesis, fibroblast proliferation, and neutrophil chemotaxis; it also regulates the functions of lymphocytes and epithelial cells and is involved in the 'acute phase response' to infection.
|
|
|
|
news articles
Microbicide gel can prevent HIV and herpes infection of human ... Dec 8, 2005 Aidsmap, ...investigators measured the levels of three immune system ‘cytokines’ that are released during inflammation: interleukin-8, interleukin-1 beta and secretory ...
|
|